
Strange News: Big Pharma, Mysterious Airport Moans and Bret Favre
Stuff They Don't Want You To Know
00:00
Is That a Good Idea?
Purdue Pharma paid $900 million to settle allegations that it lied about the addictive nature of OxyContin. The company's stock price went up on Wednesday after a drug called Le Canamab was approved for use in Alzheimer's patients. This podcast is brought to you by pharmaceuticals. We try to be easy to find online stories from you, so we can't wait to hear them!
Play episode from 40:29
Transcript


